Serotype-specific anti-CPS Igs that mediate opsonophagocytosis are generally regarded as the most important factor for immunologic protection against pneumococcal infection, and purified CPSs from many serotypes have therefore been used in pneumococcal vaccine formulae for more than half a century (3, 4). This evidence concerns the gene CAD and pneumococcal infection.